The Armenian Genocide Museum-Institute (AGMI) in Yerevan commemorated the 110th anniversary of the Armenian Genocide with a three-day international conference.  Titled “A Century of Armenian Genocide ...

It’s the night before an assignment is due. Your fingers hover over the keyboard. You’ve done the readings and attended the ...

At this year's ASCO meeting, three oral presentations of IBI363 reported encouraging Phase 1/2 clinical data in the first three indications explored—NSCLC, CRC, and melanoma—focusing on IO ...

SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

HENDERSON, Nevada, June 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces two oral presentations featuring its Nu ...

Connect Biopharma Announces Two Oral Presentations At The European Academy Of Allergy And Clinical Immunology (EAACI) 2025 Annual Congress. Date. 2025-06-03 09:01:44. Share on Facebook; ...

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties Provided by PR Newswire Jun 5, 2025, 1:00:00 AM.

Among the patients with PD-L1 TPS<1%, IBI363 demonstrated outstanding efficacy signals: in the 1/1.5 mg/kg group (N=10), the confirmed ORR was 30.0% and the DCR was 90.0%, while that of the 3 mg ...

--Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease, today announced ...

Taysha Gene Therapies Announces Details For Oral Presentations At The 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates From The TSHA-102 Clinical Program Date 2025-06-03 05:30:56 ...

YANTAI, China, June 2, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a ...

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...